| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.24 | 0.06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.07 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |